SkrInt: Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients

Sponsor
University Hospital of North Norway (Other)
Overall Status
Recruiting
CT.gov ID
NCT06012942
Collaborator
The Royal Norwegian Ministry of Health (Other), Haukeland University Hospital (Other), University Hospital, Akershus (Other), Trondheim University Hospital (Other), Bodø Hospital (Other)
300
5
41.8
60
1.4

Study Details

Study Description

Brief Summary

The primary aim is to study change of critical frailty scale (CFS) and health related quality of life (EQ-5D-5L) in a long-term follow-up of ICU survivors. We aim to identify important ICU related predictors for change in CFS and EQ-5D-5L in long term follow up (1 yr).

Secondary aim is to investigate how CFS pre-admission is related to intrahospital treatment intensity level, severity score and mortality.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a multi-centre norwegian observational, prospective multicenter Norway coordinated from University hospital North Norway, Tromso.

    The study is approved by The Regional Committee for Medical Research Ethics Northern Norway.

    The following scores will be assessed by asking the patient and relative during ICU stay:

    CFS, EQ5DL before current critical illness.

    The following demographic and clinical data will be retrieved from the medical records:

    Comorbidity before critical illness, reasons for ICU admission, daily severity score (SOFA- score), length of mechanical ventilation, dialysis, tracheostomy, Habitat before and after ICU treatment, ICU and hospital length of stay, complications retrieved during intensive care treatment, mortality, limitation of treatment.

    The patients will be followed up with telephone interview after hospital discharge for evaluation of: Comorbidity, CFS, EQ5DData for all sites are collected and managed using RedCap electronic data capture tools.

    Three research nurses will do the follow up with telephone interviews on all sites and record the data in RedCap.

    We aim to enroll 300 patients before 31. Des 2024.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients
    Actual Study Start Date :
    Jul 7, 2022
    Anticipated Primary Completion Date :
    Dec 31, 2023
    Anticipated Study Completion Date :
    Dec 31, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Change in Clinical frailty score [Change in Clinical Frailty score from 3 months to 12 months follow up]

      Score from 1 to 9.

    2. EuroQol 5-Dimension 5-Level (EQ-5D-5L) [Change in EQ-5D-5L from 3 months to 12 months]

      The scale measures quality of life on a 5-component scale

    3. Mortality [ICU-stay or subsequent 12 months.]

      Mortality during ICU-stay or subsequent 12 months.

    Secondary Outcome Measures

    1. ICU readmission [Long-term follow up (1 yr)]

      ICU readmission rate

    2. ICU-LOS [Through total ICU stay, up to 3 months]

      ICU length of stay

    3. Treatment intensity level [From inclusion in the study to discharge from intensive care unit, up to three months.]

      ICU treatment intensity level

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • = 65 years

    • ≥ 24 hours mechanical ventilation

    • Written informed consent from patient or next of kin

    Exclusion Criteria:
    • Readmission of patient included in the study

    • Not possible to obtain a valid CFS or and EQ-5D-5L at admission or follow-up of CFS because of social context or language.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Akershus University hospital, General Intensive care department Lørenskog Nordbyhagen Norway 1478
    2 Haukeland University hospital, General Intensive care unit Bergen Norway 5021
    3 Nordlandssykehuset Bodø, Intensivavdelingen Bodø Norway 8005
    4 University Hospital of North Norway Tromsø Norway 9038
    5 Trondheim University hospital, General Intensive care department Trondheim Norway 7006

    Sponsors and Collaborators

    • University Hospital of North Norway
    • The Royal Norwegian Ministry of Health
    • Haukeland University Hospital
    • University Hospital, Akershus
    • Trondheim University Hospital
    • Bodø Hospital

    Investigators

    • Principal Investigator: Shirin K Frisvold, MD/PhD, University Hospital of North Norway

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University Hospital of North Norway
    ClinicalTrials.gov Identifier:
    NCT06012942
    Other Study ID Numbers:
    • HNF1632-22
    First Posted:
    Aug 28, 2023
    Last Update Posted:
    Aug 28, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital of North Norway
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 28, 2023